Penumbra Brain Catheter Recall Issued Due to Manufacturing Error

A recall has been announced for the Penumbra System Reperfusion Catheter 32 due to a manufacturing error, which could cause the devices to fail and lead to life-threatening injury. 

The Penumbra Catheter recall was classified on December 8 as a Class I medical device recall by the FDA, meaning that the agency believes the defect is likely to cause severe injury or death. The recall came after reports that the devices are suffering mid-shaft joint failures.

The catheters are used to provide a blood supply to the brain in patients who have experienced a severe stroke. The FDA became aware of the problem after the manufacturer, Penumbra, Inc., sent an Urgent Voluntary Field Removal letter on October 28 to customers, instructing them to inspect their inventory and quarantine it for return to Penumbra. The FDA did not say whether the defective catheters have led to any reported injuries or death.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall affects 77 Penumbra System Reperfusion Catheter 032 systems, 28 of which were marketed in the United States. The catheters have a catalog number of PSC032 and a lot number of F15020.

Penumbra employees will contact customers who received the catheters and arrange to have them returned and replaced. Any customers with questions can contact Penumbra at 1-888-272-4606.

Healthcare professionals or consumers who experience a problem with these devices are encouraged to file a report with FDA’s MedWatch adverse event reporting program at www.fda.gov/MedWatch/report.htm.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.